Certara, a global drug development consultancy, announced on Sept. 13 its acquisition of Pirana, a popular pharmacometrics modeling workbench.
Pirana, which was developed in 2007 by Ron Keizer, is used for “connecting and organizing pharmacometric modeling results,” and offers interfaces to a number of pharmacometrics modeling platforms.
“We are thrilled that Pirana, which has been used by our scientists for years, will now be part of the Certara technology portfolio,” Certara Strategic Consulting President Thomas Kerbush said in a statement.
Keizer says he’s “confident that Pirana has found the right home with Certara.”
“Not only does Certara have a formidable arsenal of products for quantitative scientists, but it is the undisputed leader in educating the larger community about the myriad benefits that modeling and simulation can provide for today’s drug developers,” he said in a statement.
Click here to read the full press release on Certara’s website.
